Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Tuesday that Arbli (losartan potassium) Oral Suspension, 10 mg/mL, has ...

Expanded Coverage Reaches Over 100 Million Covered Lives Nationwide COMMACK, NY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC.

Scienture launches Arbli, the first FDA-approved liquid losartan, expanding hypertension treatment access across US healthcare institutions.

PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots ...

Losartan is a drug used to treat high blood pressure. It's important that your doctor or pharmacist knows what medicines you are already taking, including those bought without a prescription and ...

Investing.com -- Scienture Holdings Inc (NASDAQ:SCNX) stock surged 61.4% after the company announced it has begun commercial sales and fulfillment of the first customer orders for Arbli™, its ...

Parsippany-based Teva Pharmaceuticals USA Inc. has expanded its voluntary consumer-level recall originally initiated on April 25, 2019 in the United States of losartan potassium tablets. In a press ...

Global drug giant Teva Pharmaceuticals USA, Inc. has joined the increasing number of companies yanking a popular blood pressure and heart medicine from shelves over concerns long-term use could ...

A multibillion-dollar pharmaceutical company has expanded its national recall of a prescription drug used to treat high blood pressure and congestive heart failure for the fourth time since December ...

Several clinical trials have demonstrated the relative tolerability of losartan. [8,14,18,19,20] The most frequent adverse reaction, as observed in a clinical trial of 2900 patients assessing the ...

MacLeods Pharmaceuticals Limited, which recalled one lot of heart and blood pressure medication losartan in February, recalled another 32 lots of losartan Tuesday for the same reason: an impurity that ...

Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. In a Sept. 19 statement, ...